Antofagasta plc (LON:ANTO) announced a dividend on Thursday, August 19th, Upcoming.Co.Uk reports. Shareholders of record on Thursday, September 2nd will be paid a dividend of $0.24 per share by the mining company on Friday, October 1st. This represents a yield of 1.23%. The ex-dividend da
SmileDirectClub (NASDAQ:SDC) stock represents a company that promises to bring down the cost associated with teeth straightening. SDC stock has made headlines recently, but the attention has little to do with its fundamentals.
I can tell my readers are up on their current events, because this week, they sent questions about whether to buy, sell, or hold stocks that were ripped right from the headlines.
But of course, you never get the whole stock story from the news, do you? And you certainly don’t hear what you need to buy to cash in, let alone what to sell to stay safe.
I have a grand total of five buys for everyone this week, including a company that was just vindicated in court, and another one that’s buying back $60 billion in shares and boosting its dividend by 11%.
Betting on bargain stocks that have a low price-to-earnings (P/E) ratio is a convenient and common investment approach. The perception is that the lower the P/E, the higher is the value of the stock. This inference is drawn on the simple logic that a stock’s current market price does not
Digital Turbine (NASDAQ:APPS), which makes money from mobile ad spending, has had a rough summer. APPS stock fell from a peak close of $94.74 on Mar. 1 to a low close of $47.90 on Aug. 19. That’s a drop of almost 50% over six months.
Laidlaw started coverage on shares of Vincerx Pharma (NASDAQ:VINC) in a research report sent to investors on Monday morning, Analyst Ratings Network reports. The firm issued a buy rating and a $30.00 price target on the stock.
Several other brokerages have also recently commented on VINC
Ortho Clinical Diagnostics (NASDAQ:OCDX) and Meridian Bioscience (NASDAQ:VIVO) are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their risk, dividends, profitability, valuation, institutional ownership, analyst recommenda